What is considered the first-line treatment for non-life threatening abnormal uterine bleeding?

The first-line treatment for non-life threatening abnormal uterine bleeding is combination oral contraceptives, as they are effective in regulating menstrual cycles and managing bleeding. They work by providing hormonal regulation, suppressing endometrial proliferation, and stabilizing the uterine lining, which can help reduce both the frequency and amount of bleeding.

Combination oral contraceptives are particularly useful because they are non-invasive, easily reversible, and can also provide additional benefits, such as alleviating symptoms related to premenstrual syndrome (PMS) and improving dysmenorrhea. This makes them a convenient option for many women who experience abnormal bleeding without the necessity for more invasive procedures or significant medical interventions.

Other options, such as dilation and curettage or hysterectomy, tend to be reserved for more severe cases or when there is a suspicion of underlying pathology that requires surgical intervention. Intravenous estrogen therapy is typically used in acute situations where immediate control of bleeding is necessary, rather than as a first-line treatment for chronic or non-life threatening conditions.